Skip to content
COMPANY
PRODUCTS
R & D
Product Candidates Overview
Pipeline
Orphan Drug Designations
PARTNERING
INVESTOR RELATIONS
Press Releases
Events & Presentations
Stock Information
SEC Filings
XBRL Filings
Stockholder Meeting
Corporate Governance
Email Alerts
Investor Contact
BLOG
CONTACT
Press Releases
Oct 14, 2003
HEMISPHERX BIOPHARMA EXPANDS SARS PREVENTION/TREATMENT INITIATIVE
Sep 15, 2003
HEMISPHERX BIOPHARMA REPORTS ON ANNUAL MEETING
Sep 15, 2003
HEMISPHERX BIOPHARMA REPORTS ON ANNUAL MEETING
Sep 04, 2003
HEMISPHERX BIOPHARMA SIGNS AGREEMENT WITH GUANGDONG MEDICINE GROUP CORPORATION
Aug 20, 2003
HEMISPHERX BIOPHARMA SECOND QUARTER EARNINGS ANNOUNCED
Aug 18, 2003
HEMISPHERX BIOPHARMA ENTERS INTO SALES AND MARKETING AGREEMENT WITH ENGITECH FOR ALFERON N
Aug 11, 2003
HEMISPHERX BIOPHARMA ENTERS INTO AGREEMENT WITH THE JOHANN WOLFGANG GOETHE UNIVERSITY, INSTITUTE OF VIROLOGY
Aug 04, 2003
HEMISPHERX BIOPHARMA RECEIVES NEW PATENTS FOR ORAL DOSED BROAD-SPECTRUM IMMUNE ACTIVATORS
Jul 29, 2003
HEMISPHERX REPORTS AMPLIGEN PREVENTS DESTRUCTION OF NERVE CELLS AND INCREASES SURVIVAL RATES IN FLAVIVIRUS INFECTION
Jul 15, 2003
HEMISPHERX REPORTS NEW HIV TREATMENT DATA ON AMPLIGEN AT THE 2nd IAS CONFERENCE ON HIV PATHOGENESIS AND TREATMENT
60
61
62
63
64
65
66
67
68
69
70
<<
<
>
>>
Privacy